Wealthedge Investment Advisors’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-35,199
Closed -$56.7K 209
2024
Q4
$56.7K Buy
+35,199
New +$36.6K 0.03% 170

Other funds holding STIM

Wealthedge Investment Advisors's STIM Position: Q1 2025 in Review

Wealthedge Investment Advisors sold out of Neuronetics (STIM) in Q1 2025, closing a stake of 35,199 shares — an estimated $56.7K sold.

Wealthedge Investment Advisors first reported a position in STIM in Q4 2024 and held it in 1 quarter. The position peaked at $56.7K in Q4 2024. 102 funds tracked by Wall St. Rank hold STIM as of Q1 2025.

  • Wealthedge Investment Advisors reported no remaining Neuronetics position as of Q1 2025 after selling out during the quarter.
  • Wealthedge Investment Advisors sold 35,199 Neuronetics shares in Q1 2025, an estimated $56.7K.
  • Wealthedge Investment Advisors first reported a position in Neuronetics in Q4 2024 and held it in 1 quarter.
  • Wealthedge Investment Advisors's Neuronetics position peaked at $56.7K in Q4 2024.
  • 102 funds tracked by Wall St. Rank held Neuronetics as of Q1 2025.

Based on Wealthedge Investment Advisors's 13F filing for Q1 2025, filed 13 May 2025.